Cowealth Medical Holding CoROCO:4745 50 EV-to-FCF is 3,555.50 as of Jul. 13, 2026, which is 98939% above its 10-year median of 3.59. GuruFocus rates ROCO:4745 with a GF Score™ of 50/100 and a GF Value™ of NT$13.11 (Fairly Valued). The stock has 6 warning signs investors should review. Among 416 Medical Devices & Instruments companies, Cowealth Medical Holding Co ranks worse than 99.52% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Cowealth Medical Holding Co's Enterprise Value is NT$2,972 Mil.
Cowealth Medical Holding Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was NT$1 Mil. Therefore, Cowealth Medical Holding Co's EV-to-FCF for today is 3,555.50.
The historical rank and industry rank for Cowealth Medical Holding Co's EV-to-FCF or its related term are showing as below:
ROCO:4745'
s EV-to-FCF Range Over the Past 10 Years
Min: -69.61 Med: 3.59 Max: 4815.53
Current: 3555.5
During the past 13 years, the highest EV-to-FCF of Cowealth Medical Holding Co was 4815.53. The lowest was -69.61. And the median was 3.59.
ROCO:4745's EV-to-FCF is ranked worse than 99.52% of 416
companies
in the Medical Devices & Instruments industry
Industry Median: 23.305
vs ROCO:4745: 3555.50
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Cowealth Medical Holding Co (ROCO:4745) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Cowealth Medical Holding Co's PE Ratio (TTM) for today is calculated as:
Cowealth Medical Holding Co's share price for today is NT$13.80.
Cowealth Medical Holding Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-3.170.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Cowealth Medical Holding Co EV-to-FCF Related Terms
Cowealth Medical Holding Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Cowealth Medical Holding Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cowealth Medical Holding Co EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cowealth Medical Holding Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Cowealth Medical Holding Co's EV-to-FCF falls into.
Cowealth Medical Holding Co's current Enterprise Value is NT$2,972 Mil.
Cowealth Medical Holding Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cowealth Medical Holding Co (ROCO:4745) has a EV-to-FCF of 3,555.50 as of Jul. 13, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Cowealth Medical Holding Co and its competitors. This is 98939% above median its historical median of 3.59. According to the industry distribution chart, Cowealth Medical Holding Co ranks #414 out of 416 companies in the Medical Devices & Instruments industry, placing it in the top 99.5%.
Is Cowealth Medical Holding Co's EV-to-FCF too high?
Cowealth Medical Holding Co's current EV-to-FCF of 3,555.50 is 98939% above median its 10-year median of 3.59. The Medical Devices & Instruments industry median EV-to-FCF is 23.31. Cowealth Medical Holding Co's value of 3,555.50 is 15156.4% above this industry median. Based on the distribution chart, Cowealth Medical Holding Co ranks #414 out of 416 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Cowealth Medical Holding Co has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cowealth Medical Holding Co's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Cowealth Medical Holding Co ranks #414 out of 416 companies for EV-to-FCF. This places Cowealth Medical Holding Co in the lower half of its industry. The industry median EV-to-FCF is 23.31. Cowealth Medical Holding Co's value of 3,555.50 is 15156.4% above this benchmark. While the company's 10-year median is 3.59 vs. the industry median of 23.31, Cowealth Medical Holding Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.31, based on 416 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cowealth Medical Holding Co's current EV-to-FCF of 3,555.50 is 15156.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Cowealth Medical Holding Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cowealth Medical Holding Co's current EV-to-FCF is 3,555.50, which is 98939% above median its own 10-year median of 3.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cowealth Medical Holding Co stock overvalued right now?
Based on GuruFocus' analysis, Cowealth Medical Holding Co (ROCO:4745) is currently considered Fairly Valued. The stock's GF Value™ is NT$13.11, compared to a current price of NT$13.80 — trading 5.3% above its estimated fair value. The current EV-to-FCF is 3,555.50, which is 98939% above median its 10-year median of 3.59 and 15156.4% above the Medical Devices & Instruments industry median of 23.31. Cowealth Medical Holding Co's overall GF Score™ is 50/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Cowealth Medical Holding Co (ROCO:4745), the current EV-to-FCF is 3,555.50 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cowealth Medical Holding Co (ROCO:4745) Overvalued in 2026?
Based on GuruFocus' analysis, Cowealth Medical Holding Co stock appears to be overvalued.
The current stock price of NT$13.80 is trading 5.3% above its estimated GF Value™ of NT$13.11.
GuruFocus considers Cowealth Medical Holding Co to be Fairly Valued.
Key valuation signals for ROCO:4745:
EV-to-FCF: 3,555.50 (98939% above median its 10-year median of 3.59)
GF Value™: NT$13.11 vs. price of NT$13.80 (5.3% above fair value)
Industry Position: 15156.4% above the Medical Devices & Instruments median (#414 of 416)
No single metric tells the full story. See the ROCO:4745 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cowealth Medical Holding Co Ltd is mainly involved in trading medical equipment, reagents, and spare parts. Its wide range of solutions includes refined management services tailored for in-vitro diagnostic products, reagents, and consumables, an integrated platform designed for decision-making and analysis, commercialization of achievements in medical science and technology, a Multi-Channel Coaxial Time Audio Video Imaging Platform (MCCTAVIP), and an AI-assisted system for clinical diagnosis. The Group has two reportable segments: Segment A, which generates maximum revenue and sells equipment, and Segment B, which sells reagents and others. Geographically, it generates maximum revenue from China and Hong Kong, and the rest from Taiwan.
50GF Score
Get the complete analysis for ROCO:4745
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4745 has been successfully added to your 
